AGENCE DE DIAGNOSTIC NIORTAISE : revenue, balance sheet and financial ratios

AGENCE DE DIAGNOSTIC NIORTAISE is a French company founded 14 years ago, specialized in the sector Analyses, essais et inspections techniques. Based in NIORT (79000), this company of category PME shows in 2025 a revenue of 1.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - AGENCE DE DIAGNOSTIC NIORTAISE (SIREN 534800982)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 1 129 927 € 1 014 924 € 1 000 184 € 1 039 338 € 918 338 € 801 731 € 813 771 € 766 657 € 724 257 € N/C
Net income 198 767 € 182 317 € 150 889 € 100 449 € 101 684 € 122 741 € 70 290 € 4 255 € 27 995 € 22 011 €
EBITDA 324 123 € 285 552 € 257 723 € 179 487 € 172 699 € 201 170 € 129 929 € 29 481 € 65 223 € N/C
Net margin 17.6% 18.0% 15.1% 9.7% 11.1% 15.3% 8.6% 0.6% 3.9% N/C

Revenue and income statement

In 2025, AGENCE DE DIAGNOSTIC NIORTAISE achieves revenue of 1.1 M€. Over the period 2017-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +5.7%. Vs 2024, growth of +11% (1.0 M€ -> 1.1 M€). After deducting consumption (0 €), gross margin stands at 1.1 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 324 k€, representing 28.7% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 199 k€, i.e. 17.6% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2025) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

1 129 927 €

Gross margin (2025) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 129 927 €

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

324 123 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

262 587 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

198 767 €

EBITDA margin (2025) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

28.7%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 23.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

4.886%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

58.986%

Cash flow / Revenue (2025) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

22.993%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.078

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

14.4%

Solvency indicators evolution
AGENCE DE DIAGNOSTIC NIORTAISE

Sector positioning

Debt ratio
4.89 2025
2023
2024
2025
Q1: 1.1
Med: 15.81
Q3: 47.37
Good -26 pts over 3 years

In 2025, the debt ratio of AGENCE DE DIAGNOSTIC NIOR... (4.89) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
58.99% 2025
2023
2024
2025
Q1: 24.45%
Med: 45.48%
Q3: 63.24%
Good

In 2025, the financial autonomy of AGENCE DE DIAGNOSTIC NIOR... (59.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
0.08 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.25 years
Q3: 1.43 years
Good -27 pts over 3 years

In 2025, the repayment capacity of AGENCE DE DIAGNOSTIC NIOR... (0.08) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 227.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.3x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

227.045

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.266

Liquidity indicators evolution
AGENCE DE DIAGNOSTIC NIORTAISE

Sector positioning

Liquidity ratio
227.04 2025
2023
2024
2025
Q1: 170.82
Med: 250.96
Q3: 376.04
Average

In 2025, the liquidity ratio of AGENCE DE DIAGNOSTIC NIOR... (227.04) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
0.27x 2025
2023
2024
2025
Q1: 0.0x
Med: 0.41x
Q3: 3.83x
Average -23 pts over 3 years

In 2025, the interest coverage of AGENCE DE DIAGNOSTIC NIOR... (0.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 104 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 70 days. The gap of 34 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 56 days of revenue, i.e. 175 k€ to permanently finance.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

175 093 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

104 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

70 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2025) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

56 j

WCR and payment terms evolution
AGENCE DE DIAGNOSTIC NIORTAISE

Positioning of AGENCE DE DIAGNOSTIC NIORTAISE in its sector

Comparison with sector Analyses, essais et inspections techniques

Valuation estimate

Based on 53 transactions of similar company sales in 2025, the value of AGENCE DE DIAGNOSTIC NIORTAISE is estimated at 669 939 € (range 257 988€ - 1 349 697€). With an EBITDA of 324 123€, the sector multiple of 3.1x is applied. The price/revenue ratio is 0.13x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
53 tx
257k€ 669k€ 1349k€
669 939 € Range: 257 988€ - 1 349 697€
NAF 5 année 2025

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
324 123 € × 3.1x
Estimation 1 017 563 €
360 186€ - 1 807 545€
Revenue Multiple 30%
1 129 927 € × 0.13x
Estimation 150 403 €
113 305€ - 529 226€
Net Income Multiple 20%
198 767 € × 2.9x
Estimation 580 185 €
219 522€ - 1 435 787€

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 53 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Analyses, essais et inspections techniques)

Compare AGENCE DE DIAGNOSTIC NIORTAISE with other companies in the same sector:

Voir toutes les statistiques du secteur Analyses, essais et inspections techniques

Frequently asked questions about AGENCE DE DIAGNOSTIC NIORTAISE

What is the revenue of AGENCE DE DIAGNOSTIC NIORTAISE ?

The revenue of AGENCE DE DIAGNOSTIC NIORTAISE in 2025 is 1.1 M€.

Is AGENCE DE DIAGNOSTIC NIORTAISE profitable?

Yes, AGENCE DE DIAGNOSTIC NIORTAISE generated a net profit of 199 k€ in 2025.

Where is the headquarters of AGENCE DE DIAGNOSTIC NIORTAISE ?

The headquarters of AGENCE DE DIAGNOSTIC NIORTAISE is located in NIORT (79000), in the department Deux-Sevres.

Where to find the tax return of AGENCE DE DIAGNOSTIC NIORTAISE ?

The tax return of AGENCE DE DIAGNOSTIC NIORTAISE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does AGENCE DE DIAGNOSTIC NIORTAISE operate?

AGENCE DE DIAGNOSTIC NIORTAISE operates in the sector Analyses, essais et inspections techniques (NAF code 71.20B). See the 'Sector positioning' section above to compare the company with its competitors.